País: Estats Units
Idioma: anglès
Font: NLM (National Library of Medicine)
griseofulvin (UNII: 32HRV3E3D5) (griseofulvin - UNII:32HRV3E3D5)
Pedinol Pharmacal, Inc.
griseofulvin
griseofulvin 250 mg
ORAL
PRESCRIPTION DRUG
Gris-PEG (griseofulvin ultramicrosize) is indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete’s foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber’s itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: Trichophyton rubrum , Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis,Trichophyton verrucosum, Trichophyton megnini, Trichophyton gallinae, Trichophyton crateriform, Trichophyton sulphureum, Trichophyton schoenleini, Microsporum audouini, Microsporum canis, Microsporum gypseum and Epidermophyton floccosum. NOTE: Prior to therapy, the type of fungi responsible for the infection should be identified. The use of the drug is not justified in minor or trivial infections which will respond to topical agents alone. Griseofulvin is not effective in the following: bacterial inf
Gris-PEG® (griseofulvin ultramicrosize) Tablets, 125 mg, white scored, elliptical-shaped, embossed “Gris-PEG” on one side and “125” on the other. The 125 mg strength is film-coated and is available in bottles of 100 (NDC 0884-0763-04). Gris-PEG (griseofulvin ultramicrosize) Tablets, 250 mg, white scored, capsule-shaped, embossed “Gris-PEG” on one side and “250” on the other. The 250 mg strength is film-coated and is available in bottles of 100 (NDC 0884-0773-04).
New Drug Application
GRIS-PEG- GRISEOFULVIN TABLET, FILM COATED PEDINOL PHARMACAL, INC. ---------- GRIS-PEG (GRISEOFULVIN ULTRAMICROSIZE) TABLETS, USP 125 MG; 250 MG RX ONLY DESCRIPTION Gris-PEG Tablets contain ultramicrosize crystals of griseofulvin, an antibiotic derived from a species of _Penicillium_. The chemical name of griseofulvin, USP is 7-Chloro-2’, 4,6-trimethoxy-6’ β-methylspiro[benzofuran- 2(3H),1’-[2]cyclohexene]-3,4’-dione. Its structural formula is: Griseofulvin, USP occurs as a white to creamy white, odorless powder which is very slightly soluble in water, soluble in acetone, dimethylformamide, and chloroform and sparingly soluble in alcohol. Each Gris-PEG tablet contains: ACTIVE INGREDIENT: griseofulvin ultramicrosize …. 125 mg INACTIVE INGREDIENTS: Polyethylene Glycol 8000, Lactose Monohydrate, Colloidal Silicon Dioxide, Crospovidone, Magnesium Stearate, Methylparaben, Polyvinyl Alcohol, Titanium Dioxide, Polyethylene Glycol 3350, and Talc. OR ACTIVE INGREDIENT: griseofulvin ultramicrosize … 250 mg INACTIVE INGREDIENTS: Polyethylene Glycol 8000, Magnesium Stearate, Sodium Lauryl Sulfate, Methylparaben, Polyvinyl Alcohol, Titanium Dioxide, Polyethylene Glycol 3350, and Talc. CLINICAL PHARMACOLOGY MICROBIOLOGY Griseofulvin is fungistatic with _in vitro_ activity against various species of _Microsporum,_ _Epidermophyton_ and _Trichophyton_. It has no effect on bacteria or other genera of fungi. ® ® C H ClO M.W. 352.77 17 17 6 PHARMACOKINETICS Following oral administration, griseofulvin is deposited in the keratin precursor cells and has a greater affinity for diseased tissue. The drug is tightly bound to the new keratin which becomes highly resistant to fungal invasions. The efficiency of gastrointestinal absorption of ultramicrocrystalline griseofulvin is approximately one and one-half times that of the conventional microsize griseofulvin. This factor permits the oral intake of two-thirds as much ultramicrocrystalline griseofulvin as the microsize form. However, there is currently no evidence that this Llegiu el document complet